Download presentation
1
Principles of Mechanical Ventilation in ICU
Raafat Abdel Azim
2
Treatment of Respiratory Failure
ECMO PEEP ETI + MV ECCO2R NPPV O2 IVFV CFAV Drugs Secretions TTT of the cause
3
Oxygen Supplementation
Aim: PAO2 PaO2 > 60 mmHg (60:100) If < 60 abrupt of saturation & content If > 100 no more benefit Not > 50% > 24h Potential complication: O2 PaCO2
4
Methods of O2 Supplementation (O2 Devices)
Flow Rate? Patient’s IFR? AIR (21% O2)
5
O2 Devices Classification
Delivered O2 % High O2 (up to 100%) Controlled O2 (set %) Flow Capacity High Flow Low Flow
6
O2 Devices Nasal Cannula Low flow 0.5 – 5 L/min
Maximal tracheal FIO2 0.4 – 0.5 (cannot be precisely controlled, VE) FR No in FIO2 Drying and irritating effect Low flow, low O2
7
Air-Entrainment Face Masks (Venturi Masks)
O2 Devices Air-Entrainment Face Masks (Venturi Masks) High FR FIO2 precisely controlled (0.24 – 0.5) by changing jet nozzle adjusting FR Most useful in COPD patients (titratable) Air O2 High flow, controlled O2
8
Aerosol Face Masks Large side holes, large bore tubing, a nebulizer
O2 Devices Aerosol Face Masks Large side holes, large bore tubing, a nebulizer Flow matching can be evaluated by observing the aerosol mist Moderate flow, variable O2
9
O2 Devices Reservoir Face Masks FR is adjusted so that the reservoir bag remains distended High flow, high O2
10
Resuscitation Bag-Mask-Valve Unit
O2 Devices Resuscitation Bag-Mask-Valve Unit High flow, high O2 Mask held firmly over the face air entrainment High flow > 15 L/min Bag need not be compressed to supply O2
11
ABG PaO2? SaO2? PaCO2 > 6 mmHg (in 30 min) = significant retention
12
NPPV Standard Ventilator or or NPPV ventilator PS Volume cycled
Better tolerated Less effective in mouth breathers and edentulous patients Nasal mask or or Face mask NPPV ventilator PS Volume cycled Patient triggered
13
Not recommended unless the patient is:
NPPV Not recommended unless the patient is: Alert, oriented & cooperative Not having: Swallowing dysfunction Difficulty clearing secretions Hypotension Uncontrolled arrhythmias Acute cardiac ischemia Acute GI hemorrhage
14
May not be desirable with:
NPPV May not be desirable with: levels of ventilatory requirements ( C requires P) ability to adequately clear secretions (especially with face mask) Careful observation and monitoring Possible G distension & aspiration risk
15
Titrate P, V & FIO2 PaO2 & PaCO2
NPPV Settings Specialized Unit Standard Ventilator PS mode 8-12 cmH2O IPAP AC mode 10 ml/kg PEEP or EPAP Titrate P, V & FIO2 PaO2 & PaCO2
16
ETI and MV ETI when? PaO2 < 60 (FIO2 > 0.5) PaCO2 + pH
Respiratory muscle fatigue Loss of protective upper airway reflexes Ineffective cough + secretions Level of consciousness
17
MV O2 in air Time Mode How? f % (FIO2) Volume VT Others PEEP Seconds %
I:E Time Mode I E How? O2 in air MV f % (FIO2) Volume VT Alarms & Limits Wave form Flow Trig. sensitivity Others PEEP
18
Mechanism of action of the ventilator (Mode of operation): 4 phases
Inspiratory phase Cycling from E to I Cycling from I to E Expiratory phase
19
Respiratory cycle Two phases: I & E Two phase transitions:
From I to E = expiratory cycling Between E and I = inspiratory cycling Inspiration can itself sometimes have two phases: an active ‘flow’ (TI flow) phase during which gas is being delivered to the patient an end-inspiratory pause (TI pause ) The total duration of inspiration is made of the sum of these two: TI = TI flow + TI pause
20
Intra-thoracic pressures
21
Pressure gradients within the thorax
22
Distending pressures
23
Control of Parameters of Ventilation
VT f (frequency= rate) VM I:E ratio Flow Rate Flow Profile Trigger Sensitivity
24
IFR (Inspiratory Flow Rate)
VT (ml) f (b/min) Cycle time (s) IFR TI (s) TE (s) I:E L/min L/s ml/s 500 20 60/20 = 3 60 1 1000 0.5 2.5 1:5 30 2 1:2 60 L/min 600 Volume (ml) 30 L/min 500 400 300 200 100 0.5 1 1.5 2 2.5 3 3.5 4 4.5 5 5.5 6 Time (sec)
25
Inspiratory Waveforms
Constant Decelerating Accelerating (ramp) Sinusoidal (reverse ramp) Inspiration 60 Flow (L/min) 30 Expiration TI TI TI TI 30 60
26
The Ventilation Cycle
27
IPPV Paw Pmax Pplat 20 Pause IF E t ZEEP I E
28
F V P T Duration of ventilation cycle (sec) f (60/duration)
I phase (IF period, IP period) E phase VT, VM TI, TE, I:E F V P T
29
R C Inspiratory Phase During the IF period: Paw depends on:
The airway resistance (R) The total thoracic compliance (C) (V/P) R C
30
Resistance P P P P P P P P P P P P P P Flow Rate: FRP
31
Resistance Paw 20 t N R F R F
32
Raw = (PIP – Pplat) / Flow
Calculation of Airway Resistance (Raw) in a Ventilated Patient Raw = (PIP – Pplat) / Flow Example: If in a given situation, PIP = 40 cm H2O, Pplat = 38 cm H2O, flow = 60 L/min (i.e., 1 L/s), Raw will be: = (40 − 38)/1 = 2 cm H2O/L/s.
33
Compliance P P Volume C C
34
Compliance P P Volume: VP
35
During I pause Pause No gas F into or out of the lungs Paw depends only on VI & CT Gas redistributes among alveoli This improves gas distribution in the lungs of patients with small AWD (BA, smokers).
36
C R Paw t EB intubation CW rigidity Pulmonary edema Secretions
Bronchospasm Kinked ETT Paw 20 t C R
37
Compliance = V/P Dynamic compliance: = VT/(PIP-PEEP) L/cmH2O
Static compliance: = VT/(Pplat-PEEP) L/cmH2O
38
Time Constants of the Lung
In most diseases, the involvement of the lung is not uniform. Regional differences in C and R occur. Owing to this, alveoli in different parts of the lung behave differently; diseased alveoli take longer to fill and to empty. The rate of filling of an individual lung unit is referred to as its time constant. For a particular lung unit Time Constant = R x C
39
It takes the equivalent of 5 time constants for the lung to completely fill (or to empty).
In the time afforded by one time constant, 63% of the lung will fill (or empty); two time constants allow 86% of the inspiratory or expiratory phase to be completed; three time constants allow for 95%, and four time constants for 98%. 100 5 98 95 4 86 3 63 2 1
40
Example: A lung unit with a normal Raw of 1 cm H2O/L/s and a normal compliance of 0.1 L/cm H2O would have a time constant of: = 1 × 0.1 = 0.1 s Five times this is 0.5 s, which would be the time required for this unit to fill or empty satisfactorily. This information comes useful while setting a ventilator’s TI and TE Since diseased air units take longer to fill, deliberately prolonging the TI may enable such units to participate more meaningfully in gas exchange
41
Goals of Mechanical Ventilation
42
Provide appropriate O2 supplementation
Assure adequate alveolar VM work of breathing (WOB) patient comfort during respiration
43
necessary to maintain the desired PaCO2
To provide adequate minute alveolar ventilation and to side effects necessary to maintain the desired PaCO2 PPV ITP
44
Adequate Ventilation PaCO2 of 40 mmHg = 5.3% of 760 mmHg
Goals Adequate Ventilation PaCO2 of 40 mmHg = 5.3% of 760 mmHg 40/760 = 0.053 Normal resting VCO2= 200 ml/min= 0.2 L/min This requires VM of 3.8 L 0.2/ ? = 0.053 0.2/ = Add dead space (VD) 3.8 L/min
45
150 ml in a 70 Kg (154 pound) adult = 0.15 x 10 (f) =
Goals, Adequate Ventilation N = 2.2 ml/Kg (1 ml/pound) 150 ml in a 70 Kg (154 pound) adult = 0.15 x 10 (f) = Required VM = = A larger VM is required for patients who have VD or VCO2 1.5 L/min 5.3 L For VCO2 For VD VD phys = VD ana + VD alv VD ana = conducting airways = 150 ml in a 70 Kg adult VD alv is created when non-perfused alveoli are ventilated (negligible in health, expands in disease) This 150 ml of VD ana is reduced by ETT and can be cut down to about 60% by tracheostomy
46
When VCO2 & VD are stable: VM 1/ PaCO2 VM x PaCO2 = constant
Goals, Adequate Ventilation When VCO2 & VD are stable: VM 1/ PaCO2 VM x PaCO2 = constant e.g., PaCO2 = 50 mmHg with VM = 5 L/min VM to 7 L/min PaCO2 to 36 mmHg V1 x P1aCO2 = V2 x P2aCO2
47
VM =VT x f Manipulation of VT has a different effect on the PaCO2 than does altering f. Consider the following: A set VT of 500 ml and f of 10 b/min results in a VM of 500 × 10 = 5,000 ml/min. The same VM can be produced by a VT of 250 ml delivered at f of 20 b/min, i.e., 250 × 20 = 5,000 ml/min. If, however, the VD is taken into consideration, the implications of these two settings are vastly different. Assuming a VD phys of 150 ml, the alveolar ventilation (the effective ventilation or the ventilation that takes part in gas exchange) in the first example would be: (500 – 150) × 10 = 3,500, and in the second example would be: (250 – 150) × 20 = 2,000. PaCO2 is inversely proportional not to all of the VM, but to that part of the ventilation that is independent of VD (i.e., the alveolar ventilation VA)
48
Goals Side effects PPV PVR RVA ITP CO VR EDV
49
Goals, Side Effects PPV ITP VD PA > PAP
50
All these effects mean Paw
Goals All these effects mean Paw Therefore, a goal of PPV is to mean Paw while maintaining adequate ventilation and oxygenation
51
Effect of IFR on mean Paw
Mean Paw = area under the curve
52
Modes (examples) Breathing support CPAP Volume controlled IPPV (CMV) A
AC IMV SIMV PSV BIPAP APRV Other modes Volume controlled IPPV (CMV) Pressure controlled (PCV) (PLV) IRV
53
Volume Controlled Ventilation (Controlled Mode Ventilation) (CMV) (IPPV)
Initial settings: f /min VT 8-10 ml/Kg FIO2 1 I:E 1:2 (1:3 in COPD) Aim pH 7.36 : 7.44 PaO2 60: 100 mmHg PaCO2 36: 44 mmHg Adjust settings (ABG, SpO2 > 92-94%)
54
IPPV Preset f & VT No patient interaction with ventilator
Advantage: rests muscles of respiration Disadvantages: requires sedation/NMB, potential adverse hemodynamic effects, muscle atrophy
55
IPPV Paw Pmax Pplat 20 Pause IF E t ZEEP I E
56
Inspiratory Plateau Pressure (Pplat)
Paw at end of I with no gas flow present It estimates PA at end I Indirect indicator of alveolar distension
57
I:E Ratio Spontaneous breathing I:E = 1:2
TI determinants with preset V breaths: VT GFR f I pause TE passively determined
58
I:E Ratio TE too short for exhalation Auto-PEEP by TI
Breath stacking Auto-PEEP Auto-PEEP by TI GFR VT f
59
During the expiratory phase
VT I E FRC FRC PEEP PaO2 FRC IA contents Pulmonary edema ARDS PaO2
60
IPPV + PEEP Paw PEEP t
61
Expansion of collapsed perfused alveoli PaO2 CL FRC
PEEP PEEP, When? PaO2 < 60 mmHg (FIO2 > 0.5) Action Expansion of collapsed perfused alveoli PaO2 CL FRC Prevention of absorption atelectasis Improvement of V/Q QS/QT
62
PEEP PEEP, How? 2.5-5 cmH2O increments until PaO2 > 60 (FIO2 < 0.5) Goal: PEEP with maximum improvement of PaO2 without hazards Hazards COP (VR, PVR, left septal displacement) Barotrauma (Pnx, Pnp, SC emphysema) abrupt PaO2 & COP
63
Don’t give PEEP > 15 cmH2O How to avoid COP IVFV Inotropics
Best PEEP O2 transport Static CL Best PEEP Don’t give PEEP > 15 cmH2O How to avoid COP IVFV Inotropics PA catheter
64
Intermittent PEEP (Expiratory Sigh) Paw t Pmax Int PEEP PEEP
Sigh phase t
65
Auto-PEEP Can be measured on some ventilators
peak, plateau, and mean Paw Potential harmful physiologic effects
66
Pressure-limited ventilation
(PLV) (PCV) Paw Pmax Pplat t
67
PCV Used to limit inflationary pressures Allows setting of TI
Complexity of interacting ventilatory variables
68
Inverse Ratio Ventilation (IRV)
Paw Improves oxygenation Neonates ARDS 20 Alveolar recruitment by creating auto PEEP I E t No advantage over 1:1 (+PEEP) at f < 15
69
FIO2 requirements > 0.6 or SaO2 < 90%
IRV Hypoxemic RF Optimize PEEP FIO2 requirements > 0.6 or SaO2 < 90% Consider IRV VC- IRV PC- IRV IFR I pause I:E with decelerating flows Most effective
70
No uniformly accepted criteria. Proposed criteria:
Indications of IRV ARDS with severe hypoxemic RF (especially with FIO2 requirements and PEEP) No uniformly accepted criteria. Proposed criteria: VC-IRV: FIO2 > 0.6 or PEEP >10 cmH2O to maintain SaO2 >90% PC-IRV: Above parameters + PIP > 45 cmH2O
71
Spontaneous Breathing (SB)
Breathing Support Point of Reference: Spontaneous Breathing (SB)
72
SB Paw +ve t -ve
73
CPAP Paw CPAP t
74
CPAP No machine breaths delivered Allows SB at elevated baseline P
Patient controls f & VT
75
Assisted Ventilation (A)
Paw Patient f and timing Hazard: hypoventilation A No A t S If or No S
76
Assist-Control (AC) Paw A+C Provides a minimum f below which C
77
AC Preferred initial mode in most situations Preset VT & minimal f
Additional patient-initiated breaths receive preset VT Advantages: WOB; allows pt. to modify VM Disadvantages: potential adverse hemodynamic effects or inappropriate hyperventilation
78
IMV PaCO2 < apneic threshold no SB IMV = IPPV
Preset VT and f Paw SB is allowed Muscle atrophy is less likely S t IMV PaCO2 < apneic threshold no SB IMV = IPPV
79
Indications of IMV Drug overdose Intermittent heavy sedation
Unstable ventilatory drive Weaning (may be combined with PSV)
80
SIMV Paw t Preset VT and f Synch. Mandatory Mandatory NO S
t Triggering window
81
SIMV Preset VT at a preset f
Additional SBs at VT & f determined by patient Often used with PSV Indications: 1ry means of MV if adequate VE is delivered Severe respiratory alkalosis To prevent auto PEEP Weaning
82
SIMV Potential advantages Better patient-ventilator interaction
Less hemodynamic effects Potential disadvantages Higher WOB > CMV, AC
83
Pressure Support Ventilation (PSV)
(Inspiratory Pressure Support = IPS) (Assisted Spontaneous Breathing = ASB) Paw PSV Spont. t Trig. Sensitivity
84
PSV Paw CPAP t
85
PSV Pressure assist during SB (= ASB)
P assist continues until inspiratory effort Delivered VT dependent on I effort & R/C of lung/thorax
86
PSV Potential advantages Indications: Patient comfort WOB < SB
May enhance patient-ventilator synchrony Used with SIMV to support SB Indications: Stable patients receiving long-term MV (WOB) Weaning
87
PSV Potential disadvantages
Variable VT if pulmonary R/C changes rapidly If sole mode of ventilation, apnea alarm is only backup Gas leak from circuit may interfere with cycling
88
Apnea Ventilation Paw IPPV Apnea alarm CPAP 15 s t Apnea time 15-60 s
89
Biphasic Intermittent Positive Airway Pressure
Paw BIPAP (PCV+) P & T can be independently set Spont. P2 PCV P1 Spont. t T high T low
90
SB superimposed on standard PCV
91
E valve PCV: closed BIPAP: controlled
92
BIPAP Auto Flow Auto flow application of the "open breathing system" even to Volume Controlled ventilation modes Can be used + any Volume oriented mode like IPPV SIMV MMV
93
Mode Contribution of SB IPPV-BIPAP No SB SB only at P level SIMV-BIPAP Continuous SB, both P levels are equal CPAP Continuous SB at 2 P levels Genuine BIPAP
94
SB possible at all times (open breathing system) Patient comfort
BIPAP SB possible at all times (open breathing system) Patient comfort Patient is never locked out No fighting against the ventilator Can cough and clear his airways at any time Sedation/MR required Improved SB Proph. & ttt of atelectasis No barotrauma or CVS Full ventilatory support, No switching between modes is required
95
Airway Pressure Release Ventilation (APRV)
SB on 2 CPAP levels P high PAO2 E P low CO2
96
MV is achieved by instead of Paw If no SB, APRV = PC-IRV
Barotrauma ( Pp – Pmean) CVS Indications: (not clear) Mild ALI Alveolar hypoventilation states with minimal airflow obstruction
97
Bilevel Positive Airway Pressure (BiPAP) System
A home care device PSV to augment patient ventilation A non-invasive alternative to traditional management in non life support applications P 2 levels of P P Cycling between the 2 levels is in response to patient F If the patient fails to initiate P change a timed phase
98
Useful in (home care): Obstructive sleep apnea COPD
BiPAP Useful in (home care): Obstructive sleep apnea COPD Musculoskeletal disorders
99
BIPAP = PCV + SB at all times
APRV = similar + extended times at higher Ps BiPAP system = a non continuous form of breathing support
100
Advantages of different modes
Rests muscles of respiration CMV Patient determines amount of ventilatory support WOB AC Improved patient-ventilator interaction Interference with normal CV function SIMV Patient comfort PSV Allows limitation of PIP Control of I:E PCV
101
Disadvantages of different modes
No patient-ventilator interaction Requires sedation/NMB Muscle atrophy Potential adverse hemodynamic effects CMV May lead to inappropriate hyperventilation AC WOB compared to AC SIMV Apnea alarm is only backup Variable effect on patient tolerance PSV Potential hyper- or hypoventilation with R/C changes PCV
102
High Frequency Ventilation (HFV)
What is it? VT (1-3 ml/kg) , f Types: Applied to chest wall: HF body surface oscillations Applied at air openings: HFPPV b/min (60-100) HFJV b/min ( ) HFO b/min ( )
103
Advantages: Raw and CL don’t affect efficacy of ventilation
HFV Advantages: Raw and CL don’t affect efficacy of ventilation Paw no COP, no barotrauma Reflex suppression of SB no need for sedatives/MR
104
Bronchoscopy, upper AW procedures ARDS
HFV Indications BP fistula Bronchoscopy, upper AW procedures ARDS Patients at risk for barotrauma (stiff L + Paw) Patients who cannot be intubated ICP Shock Thoracic surgery (e.g., descending A. Aneurysm) Lithotripsy
105
Permissive Hypercapnia
Acceptance of PaCO2, e.g., VT to peak Paw Contraindicated with ICP Consider in severe asthma and ARDS
106
Pediatric Considerations
Infants (< 5 kg) Time-cycled, PLV PIP initiated at 18–20 cm H2O Adjust to adequate chest movement or exhaled VT 10–15 mL/kg Low level of PEEP (2–4 cm H2O) to prevent alveolar collapse
107
Children SIMV mode VT 10 mL/kg Flow rate adjusted to yield desired TI Infants 0.6–0.7 secs Toddlers 0.8 secs Older 0.9–1.0 secs f <18-20 /min PEEP 2-4 cm H2O
Similar presentations
© 2024 SlidePlayer.com Inc.
All rights reserved.